After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
AGIO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Agios Pharmaceuticals Inc is $2.53B. A total of 0.55 million shares were traded on the day, compared to an average of 467.08K shares.
In the most recent transaction, Jones Cecilia sold 2,542 shares of AGIO for 49.03 per share on Sep 26 ’24. After the transaction, the Chief Financial Officer now owns 20,158 company shares. In a previous transaction on Aug 08 ’24, Goff Brian sold 11,091 shares at 42.75 per share. AGIO shares that Chief Executive Officer owns now total 78,792.
Among the insiders who bought shares, Goff Brian acquired of 11,091 shares on Aug 08 ’24 at a per-share price of $42.75. In another insider transaction, Gheuens Sarah sold 3,705 shares at $43.85 per share on Jul 01 ’24. Company shares held by the Chief Medical Officer now total 43,736.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, AGIO has a high of $53.28 and a low of $20.35.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $11.61, while its Total Shareholder’s Equity was $1.29B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.20.
